RAB10 and Parkinson disease: As the G2019S-LRRK2 mutation is considered pathogenic in PD cases, a rough initial estimation of a pathogenic level of Rab phosphorylation may be represented through the average ratios found in the mutation carriers, or ~ 50% pT73-Rab10 to total Rab10.